drugset / Trial / NCT04768673

A Study to Investigate the PK and Safety of CKD-393

NCT04768673

Phase 1 Completed 26 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A clinical trial to investigate the pharmacokinetics and safety after oral administration of CKD-393

Timeline

Start
2021-03-26
Primary completion
2021-04-22
Completion
2021-04-27

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-393 Unknown Oral
Subject D501 Unknown Oral
Subject D759 Unknown Oral
Subject H053 Unknown Oral